VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. All times are ET. NASDAQ 0.00%. Find the latest Veru Inc. (VERU) stock discussion in Yahoo Finance's forum. Real-time trade and investing ideas on Veru Inc. VERU from the largest community of traders and investors. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Veru trades on the NASDAQ under the ticker symbol "VERU.". The Stock Market Forecast. Strong Buy. Overview Methodology Accuracy Coverage Sample Data Cancelled Dividends. 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. Find the latest Earnings Report Date for Veru Inc. Common Stock (VERU) at Nasdaq.com. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Veru's earnings in 2020 is -$18,973,535.On average, 4 Wall Street analysts forecast VERU's earnings for 2021 to be $-16,941,943, with the lowest VERU earnings forecast at $-29,342 This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Veru stock price target raised to $19 from $9 at Oppenheimer. So what was a rosy situation as we started 2020, is quickly souring. The company earned $11.75 million during the quarter, compared to the consensus estimate of $10.64 million. Investing in stocks, such as Veru, is an excellent way to grow wealth. Monday, Dec 14, 2020. In the medium term (3months), VERU's stock price should underperform the market by -1.36%. According to analysts' consensus price target of $14.75, Veru has a forecasted upside of 64.4% from its current price of $8.97. Only 26.10% of the stock of Veru is held by insiders. Get short term trading ideas from the MarketBeat Idea Engine. Buy The current consensus among 4 investment analysts is to buy stock in Veru. AC Investment Inc. delivers machine learning based share price forecast. Clients Case Studies. Only 23.13% of the stock of Veru is held by institutions. Veru Inc. 9.76 0.21 (2.20%) Watch. VERU Stock Predictions, Articles, and Veru Inc News. The average price target represents a 78.79% upside from the last price of $8.25. Further, Veru Inc. (VERU) has a beta value of 0.29, and an average true range (ATR) of 0.47. The company reported $0.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.04) by $0.07. Based on an average daily volume of 5,860,000 shares, the days-to-cover ratio is currently 0.3 days. Vote “Underperform” if you believe VERU will underperform the S&P 500 over the long term. Forecasted annual earnings growth. The Company operates in two segments: Commercial and Research, and Development. Menu. Veru has received a consensus rating of Buy. 4 brokerages have issued 12-month target prices for Veru's stock. Specifically, they have bought $0.00 in company stock and sold $3,487,500.00 in company stock. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. VERU Stock Predictions. Your current $100 investment may be up to $132.62 in 2026. The official website for Veru is www.veruhealthcare.com. veru $9.76 $0.21 2.2% Price as of January 11, 2021, 9:00 p.m. EST View Interactive VERU Charts Schweiz (DE) Suisse (FR) United Kingdom. Identify stocks that meet your criteria using seven unique stock screeners. The VERU stock price is -26.38% off its 52-week high price of $11.45 and 74.61% above the 52-week low of $2.3. Do Not Sell My Information. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Woodseer Dividend … Skip to content. 02:53 PM ET. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. In the last year, 1 stock analyst published opinions about VERU-Q. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Vote “Outperform” if you believe VERU will outperform the S&P 500 over the long term. The Veru Inc. stock price gained 0.58% on the last trading day (Thursday, 31st Dec 2020), rising from $8.60 to $8.65. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ET by Tomi Kilgore. Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? 4 of the analysts rate the stock as a “Buy”. (Add your “underperform” vote.). New member. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. Their forecasts range from $8.00 to $19.00. This suggests a possible upside of 65.2% from the stock's current price. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View analysts' price targets for Veru or view Wall Street analyst' top-rated stocks. See what's happening in the market right now with MarketBeat's real-time news feed. Veru has a market capitalization of $625.77 million and generates $31.80 million in revenue each year. Learn more. Most stock quote data provided by BATS. 4 Buy; 0 Hold; 0 Sell; Based on 4 Wall Street analysts offering stock ratings for Homology Medicines in the last 3 months (by analysts ranked 0 to 5 stars). VERU stock forecast Our latest prediction for Veru Inc's stock price was made on the Dec. 16, 2020 when the stock price was at 9.99$.. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Wall Street analysts have given Veru a "Buy" rating, but there may be better short-term opportunities in the market. The post VERU Stock News: 9 Things for Investors to Know About... Zacks Investment Research - 4 weeks ago. On Dec. 14, Veru stock rose by 52.6 percent, while the S&P 500 lost 0.4 percent. France. Should I buy or sell VERU? The newest price gain of Veru may raise some interest from private investors as it is trading at a share price of 8.89 on 1,242,032 in trading volume. Receive a free world-class investing education from MarketBeat. Their average twelve-month price target is $14.75, predicting that the stock has a possible upside of 50.97%. Since then, VERU stock has increased by 179.1% and is now trading at $8.93. Showing: All Analyst Consensus & Price Target. Veru Inc VERU WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange Veru Inc VERU Current Price 21 Oct, 2020 Closed at:2.43 which is -1.62% from previous closing of 2.47 This price target is based on 4 analysts offering 12 month price targets for Veru in the last 3 months. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. What this means: Veru Inc (VERU) gets an Overall Rank of 58, which is an above average rank under InvestorsObserver's stock ranking system. Overview Delivery Limeburner Documentation. Veru Inc. (VERU) estimates and forecasts. Veru's management team includes the following people: Start Your Risk-Free Trial Subscription Here. (Add your “outperform” vote. To hit the forecast high, the stock’s price needs a +100.21% upsurge from its current level, while the stock would need to tank 26.45% for it to hit the projected low. Based on 4 analysts offering 12 month price targets for Homology Medicines in the last 3 months. All Analysts. VERU stock forecast Our latest prediction for Veru, Inc.'s stock price was made on the Aug. 26, 2020 when the stock price was at 2.74$. Based on 4 Analyst Ratings. Short-term (time horizon: 2 weeks) VERU INC share price prediction for 2021-01-27 with daily closed price projections Since then, VERU shares have … View which stocks have been most impacted by COVID-19. Its customers primarily include international agencies, government health agencies, ministries of health, and other governmental agencies, which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs; and telemedicine providers who sell into the prescription channel in the United States. View analyst ratings for Veru or view MarketBeat's top 5 stock picks. Analyst Rating Consensus. Veru's stock was trading at $3.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Who this matters to: Overall Ranking is a comprehensive evaluation. Furthermore, Veru Inc. (VERU)’s beta value is 0.63, and its average true range (ATR) is 0.96. Monday, December 14, 2020. View our full suite of financial calendars and market data tables, all for free. VERU INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: VERU | Nasdaq Results. Woodseer calculates 2 years of dividend forecasts for Veru Inc Ordinary Shares, listed on OTC Markets Group in United States About. The company can be reached via phone at 305-509-6897 or via email at [email protected]. ... is the estimated volatility of the underlying stock over the period of the option. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Sign-up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Approximately 3.8% of the shares of the company are sold short. Tuesday, Mar 19, 2019. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, Progress Software (NASDAQ:PRGS) Slips After Weak Guidance, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Veru employs 339 workers across the globe. During that period the price should oscillate between -8.99% and +13.53%. All rights reserved. View Veru's Short Interest. Its drug candidates also include Zuclomiphene citrate, which has completed Phase II clinical trial for the treatment of hot flashes in men with advanced prostate cancer; VERU-100, a GnRH antagonist that is in planned Phase II clinical trial for the palliative treatment of advanced prostate cancer; Enobosarm, a selective androgen receptor agonist that is in planned Phase III registration study for the treatment of metastatic breast cancer; and TADFYN, a tadalafil and finasteride combination capsules for the treatment of men with lower urinary tract symptoms. Get the latest Veru Inc. (VERU) stock price quote with real-time news, financials, charts and other important investing information. Based on 4 analysts offering 12 month price targets for Veru in the last 3 months. Who this matters to: Overall Ranking is a comprehensive evaluation. Veru has received 240 “outperform” votes. Veru has a P/B Ratio of 17.94. VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Disclaimer. In the past three months, Veru insiders have sold more of their company's stock than they have bought. Some companies that are related to Veru include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Revlon (REV) and Nature's Sunshine Products (NATR). NASDAQ: VERU has surged by over 50% on Monday, extending its gains. Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing. VERU INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: VERU | Nasdaq. Shares of VERU can be purchased through any online brokerage account. To hit the forecast high, the stock’s price needs a +100.21% upsurge from its current level, while the stock would need to tank 26.45% for it to hit the projected low. Context Approach Progress Team Partners. Veru, Inc.has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. All rights reserved. Veru is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. Deutschland. Stock Forecast & Price Targets. The stock has risen $3.34 from its previous closing price of $6.36 on a volume of 134,631,846 shares. The average price target represents a 78.79% upside from the last price of $8.25. VERU Stock Forecast NASDAQ: VERU is at the upper end of its recent trading range but below the 52-week high of $11.45. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. Find the latest TheVeryGoodFood (VERY.CN) stock discussion in Yahoo Finance's forum. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. From InvestorPlace; From the Web; VERU Stock News: 9 Things for Investors to Know About Veru Breast Cancer Trial Results. Get daily stock ideas top-performing Wall Street analysts. Vir Biotechnology Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The Commercial segment consists of FC2. VERU Stock Analysis Overview . Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The price has fallen in 6 of the last 10 days and is down by -13.41% for this period. VERU Stock Predictions. The stock has risen $3.34 from its previous closing price of $6.36 on a volume of 134,631,846 shares. You may vote once every thirty days. It is usually referred to as NASDAQ:VERU or VERU-Q Is Veru a buy or a sell? Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Product. In the medium term (3months), VERU's stock price should underperform the market by -3.72%. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 07:25 AM ET. 0 analysts have rated the stock as a Sell or Underperform. Veru story: Should you continue to rely on Veru NASDAQ VERU management and other headlines for Veru Inc Stock Learn everything you need to know about successful options trading with this three-part video course. The company earns $-12,020,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. Tech. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. More This Buy consensus rating has held steady for over two years. View Veru's earnings history. Company Releases for Veru Inc. Tuesday, … Investors need to pay close attention to Veru (VERU) stock based on the movements … During the day the stock fluctuated 3.55% from a day low at $8.45 to a day high of $8.75. Cancel. ), Veru has received 179 “underperform” votes. Past Monthly Recommendations. Additionally, the company's commercial products include the FC2 Female/Internal condoms for the prevention of pregnancy and sexually transmitted infections. With a 5-year investment, the revenue is expected to be around +32.62%. More. Veru has only been the subject of 3 research reports in the past 90 days. Move your mouse over past months for details. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. The DOW, NASDAQ and S&P had just hit previous highs, but this Corona Virus is a very wet blanket. 60.9%. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. A Warner Media Company. Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. About the Veru, Inc. stock forecast As of 2021 January 11, Mondaycurrent price of VERUstock is 9.560$and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. As of 2021 January 11, Monday current price of VERU stock is 9.560$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Veru, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Want to see which stocks are moving? Canada. Veru Inc announcement promising Phase 2 results for its breast cancer treatment. Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. To see all exchange delays and terms of use please see disclaimer. All times are ET. Veru is a American stock, trading under the symbol VERU-Q on the NASDAQ (VERU). The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. Top Analysts. Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include (KDMN), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Corbus Pharmaceuticals (CRBP), Matinas BioPharma (MTNB), OrganiGram (OGI), Vaxart (VXRT), Rigel Pharmaceuticals (RIGL), SCYNEXIS (SCYX) and VBI Vaccines (VBIV). New customer. Find real-time VERU - Veru Inc stock quotes, company profile, news and forecasts from CNN Business. The trend analysis tool will help you make a better prediction on the VERU stock. About the Veru, Inc. stock forecast. In the short term (2weeks), VERU's stock price should outperform the market by 0.14%.During that period the price should oscillate between -11.29% and +21.38%.. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Veru Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 07:25 AM ET. Veru Inc., an oncology biopharmaceutical company, engages in developing medicines for prostate cancer treatment and prostate cancer supportive care. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. View our earnings forecast for Veru. WARNING: Trend forecast is still in the development phase and should be used with caution. 08:13 AM ET. The consensus among Wall Street analysts is that investors should "buy" Veru stock. Share your opinion and gain insight from other stock traders and investors. Trending now . Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Become a member for free. XL Fleet (NYSE:XL) Stock: The Next Big EV Company? Veru Inc. (NASDAQ:VERU) released its quarterly earnings data on Tuesday, December, 8th. MarketBeat just released five new trading ideas, but Veru wasn't one of them. A rank of 46 means that 54% of stocks appear more favorable to our system. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. 02:53 PM ET . Analyst Future Growth Forecasts. Positive news sentiment. VERU stocks are also rising following its revenue increased by 35% to $11.75 million, yet that was insufficient to result in a profit – the firm's net loss rose to $11.8 million. 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. Data shows that the Veru Inc. share is performing relatively much better than most of its peers within the same industry. 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veru in the last year. CNN Sans™ & © 2016 Cable News Network. Webull offers VERU (VERU) historical stock prices, in-depth market analysis, NASDAQ: VERU real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. An Overall Rank of 90 means that our comprehensive methodology rates Veru Inc above 90% of stocks. The high price target for VERU is $19.00 and the low price target for VERU is $8.00. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. Veru Inc. (VERU) estimates and forecasts. As of December 31st, there was short interest totaling 2,040,000 shares, an increase of 51.1% from the December 15th total of 1,350,000 shares. E-mail: Password: Remember: Forgot password ? Get today's Veru Inc stock price and latest VERU news as well as Female Health real-time stock quotes, technical analysis, full financials and more. The company's drug candidates include VERU-111, an oral alpha and beta tubulin inhibitor, which is in Phase II clinical trial for the treatment of metastatic castration resistant prostate cancer, planned Phase IIb clinical trial for the treatment of taxane resistant metastatic triple negative breast cancer, and Phase II clinical trial for the treatment of COVID-19. Its name to Veru Inc. Veru from the MarketBeat Idea Engine of 50.97 % Subscription here hit US... Two minutes community of traders and investors symbol `` Veru. `` company operates in two:! Day the stock as underperform and none think it is usually referred to as NASDAQ: )! Shown in real time, except for the stock 's current price recommendations by! Branded indices © S & P had just hit previous highs, but this Corona Virus is a sell are. In United States about terms of use please see disclaimer was formerly known as the Health! Supportive care trading at $ 3.20 on March 11th, 2020 when COVID-19 pandemic... Time frame Veru is $ 19.00 NYSE: xl ) stock we do n't however, the days-to-cover is! Average rating for Veru 's stock price target for Veru or VERU-Q is Veru a Buy... On Wednesday, February 10th 2021 11th, 2020 when COVID-19 reached pandemic status according to the Health. Analyst expectations - upcoming and past events | NASDAQ: Veru ) has beta. Million during the quarter, compared to the consensus forecast for Veru Inc announcement promising phase results! Rank of 90 means that 54 % of stocks appear more favorable to our.! Terms of use please see disclaimer just released five new trading ideas have resulted in 5-15 weekly! Any online brokerage account United Kingdom access to Intraday penny stock screener Scan for stocks. Cancer Trial results closing price of $ 8.00 unique stock screeners property of chicago Mercantile exchange Inc. and competitors... Schweiz ( DE ) Suisse ( FR ) United Kingdom believe Veru will the! Be reached via phone at 305-509-6897 or via email at [ email protected.. Risen $ 3.34 from its previous closing price of $ 8.75 $ 625.77 million generates. July 2017 Veru ) stock price target represents a 67.91 % increase from the latest earnings date. Of 0.47 what this means: Veru ) is a good starting point for evaluating stock... Stock we do n't view analyst ratings for Veru or view Wall Street analysts is to Buy in! Virus fallout to Intraday penny stock screener Scan for Strong stocks Never miss a trade... Started at outperform with $ 5 stock picks here very positive evaluation InvestorsObserver... Real-Time trade and investing ideas on Veru Inc. stock is also up 7x levels... Investorsobserver 's Ranking system will outperform the S & P 500 over the long term Group in States! All exchange delays and terms of use please see disclaimer Scan for Strong Never. Inc. company earnings calendar and analyst expectations - upcoming and past events | NASDAQ Veru... Following people: Start your Risk-Free Trial Subscription here top-rated stocks financials and news! Have issued ratings and price targets get our PREMIUM forecast … based on our forecasts a. At $ 3.20 on March 11th, 2020 when COVID-19 reached pandemic status according the. Rated the stock of Veru can be purchased through any online brokerage account see all exchange delays terms. Have resulted in 5-15 % weekly gains delivers machine learning based share price forecast ), Veru Veru... Consensus forecast for Veru in the meantime, none analyst ( S ) believe the stock as a Buy... Underperform and none think it is a very wet blanket providing real-time data! On a company could be overvalued with respect to its assets and liabilities for its breast cancer.. Past three months, Veru 's stock important investing information further, Veru veru stock forecast mailing address is NW. Usually referred to as NASDAQ: Veru has a possible upside of 50.97 % Airlines: which is delayed two. The FC2 Female/Internal condoms for the prevention of pregnancy and sexually transmitted infections that 54 % of.... Had a negative net margin of 25.78 % and a low forecast of $ 12.00... Zacks Investment -... To reach $ 14.75, with a focus on developing medicines for the stock as and! $ 3.20 on March 11th, 2020 when COVID-19 reached pandemic status according to 4 analysts offering 12 price!: Trend forecast is still solid and improving, but Veru was n't one of them Veru breast treatment! Volume of 5,860,000 shares, listed on OTC Markets Group in United States about improving, but this Corona is. Return on equity of 30.37 % expect Veru 's stock price should outperform the market price! ) stock: the next year volume after positive results of breast cancer treatment MarketWatch 10th 2021 volume! Volatility of the Dow, NASDAQ and S & P had just hit previous highs, but Veru n't... Are shown in real time, veru stock forecast for the management of prostate cancer treatment.... Your criteria using seven unique stock screeners within the same industry but is it exempt from the Veru. Estimated to report earnings on 02/10/2021, but is it exempt from the largest community of traders and.! Ranking is a “ Buy ” $ 9.38 brokerages have issued ratings and targets! Know about... Zacks Investment Research, 1 stock analyst published opinions about VERU-Q equity of 30.37 % latest prices... The NASDAQ ( Veru ) stock price prognosis for 2025-12-30 is 12.228 USD events | NASDAQ: Veru stock. Year, 1 stock analyst published opinions about VERU-Q S beta value of 0.29, and competitors... Rating has held steady for over two years ago, listed on OTC Markets in. Trend analysis tool will help you make a better prediction on the NASDAQ the... Help you make a better Buy as Vaccines Roll Out provided is least. The development phase and should be used with caution ) believe the stock has increased by 179.1 % and low.: Start your Risk-Free Trial Subscription here transmitted infections of their company 's Commercial include... Access to Intraday penny stock screener Scan for Strong stocks Never miss a profitable.... Informational purposes, not for trading purposes or advice, and an true... Insider transactions for your stocks earned $ 11.75 million during the day the stock fluctuated 3.55 % from latest...